Xenobiotic Metabolising Enzymes: Impact on Pathologic Conditions, Drug Interactions and Drug Design

被引:13
|
作者
Rekka, Eleni A. [1 ]
Kourounakis, Panos N. [1 ]
Pantelidou, Maria [2 ]
机构
[1] Aristotelian Univ Thessaloniki, Dept Pharmaceut Chem, Sch Pharm, Thessaloniki 54124, Greece
[2] Frederick Univ, Sch Hlth Sci, Dept Pharm, CY-1036 Nicosia, Cyprus
关键词
Xenobiotic metabolism phase I II III; Cytochrome P450; Drug interactions; Drug design; Drug metabolising enzyme induction inhibition; Drug metabolism and pathologic conditions; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; LIVER MICROSOMAL CYTOCHROME-P-450; ADJUVANT-INDUCED ARTHRITIS; NITRIC-OXIDE SYNTHASE; PREGNANE X RECEPTOR; OXIDATIVE STRESS; RAT-LIVER; IN-VITRO; UDP-GLUCURONOSYLTRANSFERASE; HEME OXYGENASE-1;
D O I
10.2174/1568026619666190129122727
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Background: The biotransformation of xenobiotics is a homeostatic defensive response of the body against bioactive invaders. Xenobiotic metabolizing enzymes, important for the metabolism, elimination and detoxification of exogenous agents, are found in most tissues and organs and are distinguished into phase I and phase II enzymes, as well as phase III transporters. The cytochrome P450 superfamily of enzymes plays a major role in the biotransformation of most xenobiotics as well as in the metabolism of important endogenous substrates such as steroids and fatty acids. The activity and the potential toxicity of numerous drugs are strongly influenced by their biotransformation, mainly accomplished by the cytochrome P450 enzymes, one of the most versatile enzyme systems. Objective: In this review, considering the importance of drug metabolising enzymes in health and disease, some of our previous research results are presented, which, combined with newer findings, may assist in the elucidation of xenobiotic metabolism and in the development of more efficient drugs. Conclusion: Study of drug metabolism is of major importance for the development of drugs and provides insight into the control of human health. This review is an effort towards this direction and may find useful applications in related medical interventions or help in the development of more efficient drugs.
引用
收藏
页码:276 / 291
页数:16
相关论文
共 50 条
  • [1] In vitro drug-drug interactions of decitabine and tetrahydrouridine involving drug transporters and drug metabolising enzymes
    Sall, Carolina
    Hjorth, Christian Fogt
    XENOBIOTICA, 2022, 52 (01) : 1 - 15
  • [2] Vitamin D and drug-metabolising enzymes
    Lindh, Jonatan D.
    Bjorkhem-Bergman, Linda
    Eliasson, Erik
    PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES, 2012, 11 (12) : 1797 - 1801
  • [3] Vitamin D and drug-metabolising enzymes
    Jonatan D. Lindh
    Linda Björkhem-Bergman
    Erik Eliasson
    Photochemical & Photobiological Sciences, 2012, 11 : 1797 - 1801
  • [4] Proteomic characterisation of drug metabolising enzymes and drug transporters in pig liver
    Elmorsi, Yasmine
    Al Feteisi, Hajar
    Al-Majdoub, Zubida M.
    Barber, Jill
    Rostami-Hodjegan, Amin
    Achour, Brahim
    XENOBIOTICA, 2020, 50 (10) : 1208 - 1219
  • [5] The impact of genetic polymorphisms of drug metabolising enzymes on pharmacological response: an integrated model
    Dickinson, GL
    Proctor, NJ
    Lennard, MS
    Tucker, GT
    Rostami-Hodjegan, A
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 59 (05) : 630 - 631
  • [6] MICROSOMAL DRUG METABOLISING ENZYMES IN DIETARY HEPATIC NECROSIS
    SOSALUCE.JC
    IGLESIA, FAD
    LUMB, G
    FEDERATION PROCEEDINGS, 1970, 29 (02) : A815 - +
  • [7] The impact of a prebiotic mix, FOS-inulin, on hepatic drug-metabolising enzymes and drug efflux transporter
    Walsh, J.
    Boehme, M.
    Cryan, John. F.
    Dinan, Timothy. G.
    Griffin, Brendan. T.
    Clarke, G.
    Hyland, Niall. P.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2019, 31
  • [8] The development of drug metabolising enzymes and their influence on the susceptibility to adverse drug reactions in children
    Johnson, TN
    TOXICOLOGY, 2003, 192 (01) : 37 - 48
  • [9] Role of drug metabolising enzymes in the regulation of brain function
    Stingl, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S118 - S118
  • [10] Effect of schistosome infection on hepatic drug metabolising enzymes
    Naik, YS
    Hasler, JA
    SOUTH AFRICAN JOURNAL OF SCIENCE, 1998, 94 (06) : 301 - 302